Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo

Rudie Kortekaas, Klaus L. Leenders*, Joost C.H. Van Oostrom, Willem Vaalburg, Joost Bart, Antoon T.M. Willemsen, N. Harry Hendrikse

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Parkinson's disease (PD) is associated with a loss of neurons from the midbrain. The cause of PD is unknown, but it is established that certain neurotoxins can cause similar syndromes. The brain is normally protected from these noxious blood-borne chemicals by the blood-brain barrier which includes specialized proteins on the inside of blood vessels in the brain. These act as molecular efflux pumps and P-glycoprotein (P-gp) is an abundant representative. Vulnerability to PD appears codetermined by the genotype for the P-gp gene. We hypothesized that PD patients have reduced P-gp function in the blood-brain barrier. We used positron emission tomography to measure brain uptake of [ 11C]-verapamil, which is normally extruded from the brain by P-gp. Here, we show significantly elevated uptake of [11C]-verapamil (18%) in the midbrain of PD patients relative to controls. This is the first evidence supporting a dysfunctional blood-brain barrier as a causative mechanism in PD.

Original languageEnglish
Pages (from-to)176-179
Number of pages4
JournalAnnals of Neurology
Volume57
Issue number2
DOIs
Publication statusPublished - 1 Feb 2005

Cite this

Kortekaas, R., Leenders, K. L., Van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005). Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo. Annals of Neurology, 57(2), 176-179. https://doi.org/10.1002/ana.20369